Skip to main content
. 2012 Aug 28;21(1):68–77. doi: 10.1038/mt.2012.175

Figure 7.

Figure 7

Schematic presentation showing the mechanism underlying the efficacy of oncolytic herpes simplex virus (oHSV)-tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on resistant glioblastoma multiforme (GBM) cells.